GSK Tightens Avandia Restrictions

Law360, New York (February 7, 2011, 4:39 PM EST) -- Under orders from health regulators, GlaxoSmithKline PLC said Monday it had revised safety restrictions on the diabetes drug Avandia because of its links to heart attacks, in a move closely following a key settlement in multidistrict litigation over the drug.

GSK said its Avandia labels would include new language restricting Avandia to patients with Type 2 diabetes who were already taking a rosiglitazone-containing medicine or unable to control the disease with other drugs.

The labels also limit use of Avandia to patients who have decided not...
To view the full article, register now.